Vivanza Biosciences Ltd

Vivanza Biosciences Q3 2025 Results 📊 Revenue & Profit Growth Highlights

• Standalone Q3 2025 revenue: ₹4,493.26 lacs

• Standalone 9-month revenue: ₹10,648.51 lacs

• Consolidated Q3 2025 revenue: ₹4,525.07 lacs

• Consolidated 9-month revenue: ₹10,954.77 lacs

• Standalone Q3 2025 profit before tax: ₹16.05 lacs

• Standalone 9-month profit before tax: ₹64.12 lacs

• Consolidated Q3 2025 profit before tax: ₹19.54 lacs

• Consolidated 9-month profit before tax: ₹84.52 lacs

• Basic EPS: Standalone Q3 ₹0.04, Consolidated Q3 ₹0.05

• Company operates in agro, pharmaceuticals, and films segments

• No exceptional items or discontinuing operations reported